CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
MAP: Where DUI drivers most likely to hit you
An exclusive 5 On Your Side investigation analyzed thousands of DUI accidents over ten counties and reveals Northeast Ohio's deadliest…
EXCLUSIVE: Details of Tamir Rice shooting video
NewsChannel 5 has obtained the first description of surveillance video capturing the shooting of a 12-year-old Cleveland youth by police.
What's next in 12-year-old shooting death probe
The probe into the shooting death of a 12-year-old Cleveland youth has up to three months of review and investigation before it will be…
Unanswered questions in 12-year-old death
Questions remain four days after a 12-year-old Cleveland youth was shot to death by a Cleveland police officer.